^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Anal Carcinoma |
| Regimen: | (capecitabine + mitomycin) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
06/05/2020
Excerpt:
Local RT with or without continuous infusion 5-FU/mitomycin, mitomycin/capecitabine, or 5-FU/cisplatin (category 2B) can be considered as alternative treatment options when surgical margins are inadequate.
